Navigation Links
Cancer Drugs Emerging as Top Driver of Specialty Drug Spending
Date:10/8/2009

al attention. Clinicians and patients need to be aware of the safety concerns associated with anemia treatments that require close attention to hemoglobin levels, and consideration of the risk of thrombosis or growth of some tumor types.

Medco Opens Specialized Oncology Care Center

Marking October as the 25th Anniversary of Breast Cancer Awareness Month, Medco is making a major commitment to advancing cancer care with the opening of the oncology Medco Therapeutic Resource Center® (TRC) in its new Indianapolis pharmacy. The oncology TRC will focus on the specialized treatment of patients with common cancers such as leukemia, breast, lung, prostate and colon, as well as pediatric cancers. In addition, Medco's new oncology TRC will assist those who are prescribed specialty drugs to maintain or improve their quality of life.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter(TM) for more than 60 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2008 revenue exceeding $51 billion, Medco ranks 45th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements.
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
2. Oral Cancer Foundation to Donate Screening Devices to Free Clinics
3. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
4. Massachusetts General Hospital Selects Elekta As New Vendor for Complete Cancer Treatment Solution
5. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
6. Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery
7. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
8. Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer
9. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
10. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
11. Farletuzumab Data Presented on Phase II Clinical Trial in First-Relapsed Ovarian Cancer Subjects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... Jan. 14, 2014 InformEx, North America,s ... high-value chemistry, will hold the 30 th edition of ... Convention Center from January 21-24. (Logo: ... top pharmaceutical, fine chemical and specialty chemical companies will take ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... , ... Therapeutics, Inc. (PTC) today announced the initiation of an additional ... with nonsense mutation Duchenne/ Becker muscular dystrophy (nmDBMD) who ... is evaluating the best methods for measuring functional abilities in ...
... , VENLO, The Netherlands , Jan. 18 ... by the Lancet Oncology found that testing for high-risk types ... invasive cervical cancer than cytology (Pap testing) alone. The trial used QIAGEN,s ... HC2 HPV DNA Test), which detects the high-risk types of HPV that ...
Cached Medicine Technology:PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 2PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 3PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 4PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 5PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy 6Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 2Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 3Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 4Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 5Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer 6
(Date:4/16/2014)... 15, 2014 The Translational Genomics Research Institute (TGen) ... Founders Dinner for their support of TGen,s research into ... March 28 in Scottsdale. , Catherine Ivy, Founder and ... TGen,s John S. McCain Leadership Award, named for U.S. ...
(Date:4/16/2014)... While it is well known that fertility treatments are ... that multiples are at elevated risk of premature birth, ... Fertility and Sterility . The article ... reduce the odds of multiple births and prematurity, including ...
(Date:4/15/2014)... a recent analysis by the RECIST Working Group published in ... explored whether a more refined categorization of tumor response or ... in the RECIST database. They found that modeling target ... survival above and beyond that of the other components of ...
(Date:4/14/2014)... Ford Hospital reached a medical milestone April 3, performing ... way to access the heart. , Henry Ford is ... unique procedure called transcaval valve replacement, which accesses the ... Michigan resident Viola Waller, 80, underwent Henry Ford,s first ...
(Date:4/14/2014)... treatment decisions leaves cancer patients feeling more satisfied with ... the experience, researchers from the Perelman School of ... the journal Cancer . , In a study ... MD , an associate professor in the department in ...
Breaking Medicine News(10 mins):Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Can refined categorization improve prediction of patient survival in RECIST 1.1? 2Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3
... Day (Dec 1), India will launch a new scheme to ... Anbumani Ramadoss said here Monday. // ,"On Nov 30, ... treatment for children using paediatric anti-retroviral (ARV) drugs. We have ... four pharmaceutical companies are part of the process," Ramadoss told ...
... the United Kingdom concluded that the UK's National Health ... least// for now. The review was published in the ... series of the Health Technology Assessment Programme, part of ... Kingdom. ,An implantable pump can help heart ...
... indicates future heart problems, according to a study.,This research ... Journal of the American College of Cardiology. ... having a heart attack are at greater risk for ... depression-related screening protocols and treatment strategies. ,Known ...
... a familiar giant. Smokers around the world find it hard ... buy time by assuming that, cutting// down on the number ... latest research disagrees. ,A study published by ‘Tobacco Control’ ... number of cigarettes you smoke or continue to smoke 15 ...
... Pharma Ltd, based in Hyderabad, India, has announced the launch ... treat certain types of lung cancer. A very costly// preparation, ... imported version of the same medication, costs a whopping Rs ... first ever generic version of Pemetrexed, in the global arena. ...
... system has been developed that surpasses mammography in detecting ... had developed the system and the// University has licensed ... to make, use and sell the scanners. The National ... the Development. ,While commenting on the new ...
Cached Medicine News:Health News:Free HIV Treatment to Be Launched for Children 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 2Health News:Review Urges Restricted Use Of Devices To Keep Heart Patients Alive 3Health News:Depression After Heart Attack Means More Heart Problems 2Health News:Depression After Heart Attack Means More Heart Problems 3Health News:For Smokers Only: is Quitting = Cutting Down?? a 'grave' Issue 2Health News:New Imaging System Surpasses Mammography In Detecting Breast Cancer 2
... From the Pioneer in Digital EEG ... Digital EEG system presents the latest ... the Ceegraph VISION. This innovative system ... remote communications and information management to ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
The field of application of the SL 120 Slit Lamp extends from the anterior ocular segment and the vitreous right back to the fundus. It is the ideal configuration for observation, measurement, diagno...
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps...
Medicine Products: